Table 3.
Groups | Treatment | Number of animals | Nominal dose-level (/animal) |
---|---|---|---|
1 | 0.9% NaCl | 16 males | 0 |
15 females | |||
2 | GLA-SE | 15 males | 5 μg |
15 females | |||
3 | PRIMVAC | 15 males | 110 μg |
15 females | |||
4 | PRIMVAC + Alhydrogel® | 17 males | 110 μg + 0.85 mg |
15 females | |||
5 | PRIMVAC + GLA-SE | 15 males | 110 μg + 5 μg |
15 females |